 |
The Journal of Neuroscience, May 15, 2003, 23(10):4164-4172
Previous Article | Next Article 
Increased Expression of Brain-Derived Neurotrophic Factor Preserves Retinal Function and Slows Cell Death from Rhodopsin Mutation or Oxidative Damage
Godwin Okoye,1
Joelle Zimmer,1
Jennifer Sung,1
Peter Gehlbach,1
Tye Deering,1
Hiroyuki Nambu,1
Sean Hackett,1
Michele Melia,1
Noriko Esumi,1
Donald J. Zack,1,2 and
Peter A. Campochiaro1
Departments of 1Ophthalmology and
Neuroscience and 2Departments of
Molecular Biology and Genetics, and Institute of Genetic Medicine, The
Johns Hopkins University School of Medicine, Baltimore, Maryland
21287-9277
There are no effective treatments for inherited retinal degenerations, which are prevalent causes of visual disability. Several proteins promote the survival of various types of neurons, and increasing expression of one or more of these survival factors is a promising strategy for a new treatment. Studies examining the effects of intravitreous injections of brain-derived neurotrophic factor (BDNF) in models of inherited retinal degenerations have suggested that BDNF has little survival-promoting activity for photoreceptors. In this study, we generated double transgenic mice with doxycycline-inducible expression of BDNF in the retina. In a model of primary rod photoreceptor degeneration, expression of BDNF resulted in significant delay in photoreceptor cell death and maintenance of retinal function assessed by electroretinogram recordings. Expression of BDNF also caused strong protection of photoreceptors from oxidative damage-induced cell death. These data suggest that continuous expression of BDNF, unlike intravitreous injections, results in morphologic and functional benefit in animal models of inherited retinal degeneration. Double transgenic mice with inducible expression of survival factors provide valuable tools for selection of survival factor candidates for gene therapy.
Key words: BDNF; gene transfer; inducible transgenics; neurotrophic factors; oxidative damage; retinal degenerations
Received Dec. 11, 2002;
revised Mar. 3, 2003;
accepted Mar. 4, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
S. Corrochano, R. Barhoum, P. Boya, A. I. Arroba, N. Rodriguez-Muela, V. Gomez-Vicente, F. Bosch, F. de Pablo, P. de la Villa, and E. J. de la Rosa
Attenuation of Vision Loss and Delay in Apoptosis of Photoreceptors Induced by Proinsulin in a Mouse Model of Retinitis Pigmentosa
Invest. Ophthalmol. Vis. Sci.,
September 1, 2008;
49(9):
4188 - 4194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Abe, R. Wakusawa, H. Seto, N. Asai, T. Saito, and K. Nishida
Topical Doxycycline Can Induce Expression of BDNF in Transduced Retinal Pigment Epithelial Cells Transplanted into the Subretinal Space
Invest. Ophthalmol. Vis. Sci.,
August 1, 2008;
49(8):
3631 - 3639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Joly, V. Pernet, S. Chemtob, A. Di Polo, and P. Lachapelle
Neuroprotection in the Juvenile Rat Model of Light-Induced Retinopathy: Evidence Suggesting a Role for FGF-2 and CNTF
Invest. Ophthalmol. Vis. Sci.,
May 1, 2007;
48(5):
2311 - 2320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Rogers, R. C. A. Symons, K. Komeima, J. Shen, W. Xiao, M. E. Swaim, Y. Y. Gong, S. Kachi, and P. A. Campochiaro
Differential Sensitivity of Cones to Iron-Mediated Oxidative Damage
Invest. Ophthalmol. Vis. Sci.,
January 1, 2007;
48(1):
438 - 445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Landi, A. Sale, N. Berardi, A. Viegi, L. Maffei, and M. C. Cenni
Retinal functional development is sensitive to environmental enrichment: a role for BDNF
FASEB J,
January 1, 2007;
21(1):
130 - 139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Komeima, B. S. Rogers, L. Lu, and P. A. Campochiaro
Antioxidants reduce cone cell death in a model of retinitis pigmentosa
PNAS,
July 25, 2006;
103(30):
11300 - 11305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gauthier, S. Joly, V. Pernet, P. Lachapelle, and A. Di Polo
Brain-Derived Neurotrophic Factor Gene Delivery to Muller Glia Preserves Structure and Function of Light-Damaged Photoreceptors
Invest. Ophthalmol. Vis. Sci.,
September 1, 2005;
46(9):
3383 - 3392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Kerrison, E. J. Duh, Y. Yu, D. C. Otteson, and D. J. Zack
A System for Inducible Gene Expression in Retinal Ganglion Cells
Invest. Ophthalmol. Vis. Sci.,
August 1, 2005;
46(8):
2932 - 2939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Pardue, M. J. Phillips, H. Yin, B. D. Sippy, S. Webb-Wood, A. Y. Chow, and S. L. Ball
Neuroprotective Effect of Subretinal Implants in the RCS Rat
Invest. Ophthalmol. Vis. Sci.,
February 1, 2005;
46(2):
674 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Paskowitz, G. Nune, D. Yasumura, H. Yang, R. B. Bhisitkul, S. Sharma, M. T. Matthes, M. A. Zarbin, M. M. LaVail, and J. L. Duncan
BDNF Reduces the Retinal Toxicity of Verteporfin Photodynamic Therapy
Invest. Ophthalmol. Vis. Sci.,
November 1, 2004;
45(11):
4190 - 4196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hojo, T. Abe, E. Sugano, Y. Yoshioka, Y. Saigo, H. Tomita, R. Wakusawa, and M. Tamai
Photoreceptor Protection by Iris Pigment Epithelial Transplantation Transduced with AAV-Mediated Brain-Derived Neurotrophic Factor Gene
Invest. Ophthalmol. Vis. Sci.,
October 1, 2004;
45(10):
3721 - 3726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Hackam, R. Strom, D. Liu, J. Qian, C. Wang, D. Otteson, T. Gunatilaka, R. H. Farkas, I. Chowers, M. Kageyama, et al.
Identification of Gene Expression Changes Associated with the Progression of Retinal Degeneration in the rd1 Mouse
Invest. Ophthalmol. Vis. Sci.,
September 1, 2004;
45(9):
2929 - 2942.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|